درباره این پادکست 🔗

میزبان‌ها:
فرکانس به روز رسانی:
weekly
میانگین طول صدا:
40 minutes
مصاحبه های مهمان
اسپانسر دارد
انگلیسی
ایالات متحده آمریکا
26 قسمت
از سال 3 آوریل 2026
episodic

آخرین اپیزود 🔗

Will the 340B Rebate Model Launch in January 2027? | Jesse C. Dresser Will the 340B rebate model launch in January 2027? What happens to covered entities' cash flow when rebates are delayed or denied? In this episode of 340B Pulse, host Muhammad Atif speaks with Jesse C. Dresser of Frier Levitt, a …

جستجوی اپیزودهای گذشته

اپیزودهای قبلی 340B Pulse را جستجو کن.

اپیزود قبلی

340B rebate cash flow is the money a covered entity has tied up between buying an in-scope drug at WAC and receiving the manufacturer's rebate. Holly Herring, Vice President of Client Services at Clearway Health, explains why the 45-day submission window under the 2027 pilot is a safety net rather …
340B claims data submission is the process of reporting individual, transaction-level prescription data to a manufacturer's platform within a fixed window, usually 45 days, to keep a claim's 340B pricing intact. In this episode of 340B Pulse, Jason Bilyj, PharmD, ACE, Director of Pharmacy at Third …
HRSA audit readiness is the ability to explain, with evidence, why a 340B program operated the way it did on an ordinary day, not simply the ability to assemble documents quickly once an audit letter arrives. Mark Capuano, PharmD, MBA, who leads 340B and supply chain work in corporate pharmacy at N…
340B audit readiness is what your control systems are doing during an ordinary month when no audit is expected. Audit preparation is what happens after the HRSA letter arrives. Dr. Darra M. Edwards, who oversees 340B compliance across covered entities in 15 states and more than 50 hospitals, explai…
LifeSpring Health Systems, the FQHC in Jeffersonville, Indiana where she serves as Program Manager, has no entity-owned pharmacy. Every 340B dollar it captures moves through a pharmacy it does not own. She runs that across four separate TPAs, by herself. When a manufacturer publishes a new restrict…
A multi-state 340B program is a single covered-entity operating model applied across hospitals, clinics, pharmacies, vendors, and state regulatory environments that do not match each other. Dr. Maria Campanella, who leads 340B operations and compliance across a multi-state nonprofit health system, …
Every quarter brings another pricing impact, another piece of state legislation, another manufacturer restriction. Most covered entities have settled into bracing for the next hit.Kaitlyn Weckhorst Wood argues that the work which actually protects a program is smaller and duller than the headlines,…
Duplicate discount prevention is the process of ensuring a covered entity never claims both a 340B discount and a Medicaid rebate on the same drug unit. Vinson Tran, founder of Pharmacy Operation Solutions, explains why it's straightforward for retail pharmacy and genuinely hard for hospital mixed-…
340B rebate readiness is the operational work of identifying, validating, submitting, and reconciling 340B claims under a rebate-based model, then confirming that the rebate a covered entity is owed is the rebate it actually receives. Celeste Fowler, Executive Director of Pharmacy 340B at Piedmont …
سلب مسئولیت: پادکست و آثار هنری تعبیه شده در این صفحه متعلق به NorthArcHealth است که متعلق به صاحب آن است و به Listen Notes، Inc وابسته یا تایید نشده است.